PharmAust Limited
ASX:PAA.AX
Overview | Financials
Company Name | PharmAust Limited |
Symbol | PAA.AX |
Currency | AUD |
Price | 0.23 |
Market Cap | 111,926,052 |
Dividend Yield | 0% |
52-week-range | 0.068 - 0.535 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Michael Thurn Ph.D. |
Website | https://www.pharmaust.com |
An error occurred while fetching data.
About PharmAust Limited
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD